Biotech 365

Main menu

Skip to primary content
Skip to secondary content
  • Biotech 365
    • Contact
    • Offers
  • Biotech Companies
  • Database researchers
    • BioLeads
  • BioMarketplace
  • Biotech Jobs
  • Biopharma News

Tag Archives: David Donabedian

AM-Pharma – recombinant human Alkaline Phosphatase

Posted on 2015-04-03 by Biotech365

AM-Pharma is a biopharma company developing a proprietary recombinant human Alkaline Phosphatase (recAP) against Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.

AM-Pharma – recombinant human Alkaline Phosphatase

AM-Pharma Continue reading →

Posted in Biotech Companies, Biotech Companies Netherlands | Tagged Acute Kidney Injury, AKI, alkaline phosphatase, AM-Pharma, AM-Pharma - recombinant human Alkaline Phosphatase, AMPharma, Andrea van Elsas, Ashok Dhanrajgir, Can Ince, David Donabedian, dephosphorylation, detoxifying agent, Edwin de Graaf, Erik van den Berg, extracellular ATP, Geert-Jan Mulder, Guido Magni, HPP, human Alkaline Phosphatase, Hypophosphatasia, Inflammatory Bowel Disease, Jacques Arend, Jean-Louis Vincent, Joannidis, Joël Jean-Mairet, Klaus Breiner, lipopolysaccharides, LPS, Moderate-to-Severe UC, Patrick Honoré, Peter Verwayen, Ravindra Mehta, recAP, recombinant Alkaline Phosphatase, recombinant human Alkaline Phosphatase, Rémi Droller, Russell Greig, Sander van Deventer, Steve Connor, Tim Knotnerus, Ulcerative Colitis, William Sandborn

Follow Biotech 365 !

Follow @Biotech365

Search on Biotech 365 :

Search for Protocols :

Search on PubMed :

Eminently : be paid for your your introductions! Jobs referrals, business connections, etc…

                      About us                       Terms                       Partners                       Contact                       Offers                       RSS feed - Biotech 365                      
Proudly powered by WordPress